Descriptors of Cytochrome Inhibitors and Useful Machine Learning Based Methods for the Design of Safer Drugs
Roughly 2.8% of annual hospitalizations are a result of adverse drug interactions in the United States, representing more than 245,000 hospitalizations. Drug-drug interactions commonly arise from major cytochrome P450 (CYP) inhibition. Various approaches are routinely employed in order to reduce the...
Saved in:
Main Authors: | Tyler C. Beck (Author), Kyle R. Beck (Author), Jordan Morningstar (Author), Menny M. Benjamin (Author), Russell A. Norris (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2021-05-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Designing Safer and Greener Antibiotics
by: Nicholas Gathergood, et al.
Published: (2013) -
Design of Skin Penetration Enhancers Using Replacement Methods for the Selection of the Molecular Descriptors
by: Beshoy Abdelmalek, et al.
Published: (2012) -
Block relevance (BR) analysis and polarity descriptors in property-based drug design
by: Giuseppe Ermondi, et al.
Published: (2018) -
Combined Machine Learning and GRID-Independent Molecular Descriptor (GRIND) Models to Probe the Activity Profiles of 5-Lipoxygenase Activating Protein Inhibitors
by: Hafiza Aliza Khan, et al.
Published: (2022) -
The C-C Chemokine Receptor Type 4 Is an Immunomodulatory Target of Hydroxychloroquine
by: Tyler C. Beck, et al.
Published: (2020)